GDTC holder plans sale of 117,337 shares

A GDTC shareholder filed a notice of proposed sale of 117,337 ordinary shares on NASDAQ through Bank of Singapore, with an approximate sale date of February 12, 2026.

Rhea-AI Filing Summary

A GDTC shareholder filed a notice of proposed sale of 117,337 ordinary shares on NASDAQ through Bank of Singapore, with an approximate sale date of February 12, 2026. The filing notes that there were 11,733,712 ordinary shares outstanding at the time.

The seller previously disposed of ordinary shares over the past three months in three transactions, including 22,950 shares for gross proceeds of $43,889.34, 12,005 shares for $19,659.86, and 8,245 shares for $12,908.25. The shares being sold were originally acquired by share subscription from the issuer in April 2021 and paid for in cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the latest Form 144 filing reveal about GDTC shares?

The filing shows a GDTC shareholder plans to sell 117,337 ordinary shares on NASDAQ. These shares were acquired via a cash share subscription in April 2021, and the sale is expected around February 12, 2026, under Rule 144 conditions.

How many GDTC shares does the Form 144 holder intend to sell?

The shareholder intends to sell 117,337 GDTC ordinary shares. The notice lists Bank of Singapore as broker and NASDAQ as the exchange, with 11,733,712 ordinary shares outstanding referenced as context for the planned Rule 144 sale.

What prior GDTC share sales are disclosed in this Form 144?

The document reports three prior sales of GDTC ordinary shares in the past three months: 22,950 shares for $43,889.34, 12,005 shares for $19,659.86, and 8,245 shares for $12,908.25. These transactions provide recent trading history for the same seller.

When were the GDTC shares in this Form 144 originally acquired?

The shares were acquired on April 22, 2021 through a share subscription from the issuer. Payment was made in cash on April 20, 2021, and the current Form 144 covers a portion of that original 711,822-share acquisition.

Which broker and exchange are involved in the planned GDTC share sale?

The filing lists Bank of Singapore at 63 Market St, #22-00, Singapore as the broker. The shares are expected to be sold as ordinary shares on the NASDAQ exchange under Rule 144 requirements for resales of restricted or control securities.

What representation does the GDTC Form 144 seller make about company information?

By signing the notice, the seller represents they do not know any material adverse, non-public information about GDTC’s current or prospective operations. This representation supports compliance with securities laws governing sales by affiliates or holders of restricted securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 09:03 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001973616
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CytoMed Therapeutics Ltd
SEC File Number	001-41677
Address of Issuer	#08-22 ONE COMMONWEALTH 1 COMMONWEALTH LANE SINGAPORE 149544
Phone	6562507738
Name of Person for Whose Account the Securities are To Be Sold	mDR LTD
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Bank of Singapore 63 Market St, #22-00 Singapore U0 048942	117337	122030.48	11733712	02/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	04/22/2021	Share Subscription	Issuer			711822	04/20/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
mDR Ltd. 53 Ubi Crescent Singapore U0 408594	Ordinary Shares	12/08/2025	22950	43889.34
mDR Ltd. 53 Ubi Crescent Singapore U0 408594	Ordinary Shares	12/09/2025	12005	19659.86
mDR Ltd. 53 Ubi Crescent Singapore U0 408594	Ordinary Shares	12/10/2025	8245	12908.25

144: Remarks and Signature

Remarks	Immediately prior to filing this Form 144, mDR Limited holds 1,221,523 ordinary shares of the Issuer.
Date of Notice	02/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Edward Lee Ewe Ming
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)